News

Mason receives $4.85 million gift to increase intimate partner violence detection and reporting

The funding will help develop new tools in imaging technology using a light source that is five times better than white light for identifying and visualizing bruising across all skin tones for use by forensic nurses, social service providers, and law enforcement.

“This single largest gift to support research in the College of Public Health’s history underscores Mason faculty’s leadership in life-changing work affecting those who experience interpersonal violence,” said Melissa J. Perry, dean of the College of Public Health. “A gift of this magnitude brings transformative resources to Mason’s cross-disciplinary research and collaborative approach that takes ground-breaking research to new heights with the potential for greater use and impact.”

Mason’s acclaimed interdisciplinary research in using Alternate Light Sources for bruise detection, as featured on NBC Nightly News, is led by researchers Katherine Scafide, David Lattanzi, and Janusz Wojtusiak. The funding will expand the team’s bruise detection system that leverages artificial intelligence (AI), imaging and light technologies, forensic reports, and clinical expertise to increase data collection and access to care for trauma victims. The technology can be used across all skin tones and responds to deficits in the identification of physical injuries particularly among people with darker skin tones.

One in three women worldwide experience physical trauma at the hands of an intimate partner or stranger. In the United States, more than 10 million women and men grapple with intimate partner violence each year. Among domestic violence survivors, bruises and soft tissue trauma are the most reported injuries. When injuries are accurately documented, survivors are more likely to participate in the criminal justice process, according to recent studies on interpersonal violence and reporting. In addition, family and partner violence and elder abuse can lead to a host of other public health issues, such as infectious and noninfectious diseases, mental health trauma, and reproductive health problems.

A vital piece to success is ensuring that any AI tool has access to in-depth data from all skin tones and skin characteristics alongside human expert analysis,” said Lattanzi, an associate professor in the Sid and Reva Dewberry Department of Civil, Environmental, and Infrastructure Engineering in the the College of Engineering and Computing.

Supporters working on ending domestic violence commended the announcement.

Ruth Glenn, president of Survivor Justice Action, applauds the groundbreaking work. “In a nation where domestic violence disproportionately impacts communities of color, this innovative research holds immense promise. By prioritizing inclusivity and recognizing the unique challenges faced by survivors with darker skin tones, Scafide’s research aligns seamlessly with our vision to end domestic violence in our lifetime. Continued research on this technology not only has the potential to revolutionize the identification of bruising in diverse populations but also signifies a vital step toward justice and empowerment for those who have long been marginalized. Survivor Justice Action stands firmly in support of initiatives that demand systems change and establish resources for survivors and advocates.”

“The Scafide team’s research and findings are revolutionizing medical forensic examinations. The ability for medical professionals to visualize and identify previously ‘invisible’ injury substantively advances quality medical assessment and patient care. Visibility and documentation of trauma/ injury provide valuable forensic corroboration for law enforcement and the courts to hold offenders accountable,” said Ann Burdges, CEO of End Violence Against Women International.

This project is led by Mason’s College of Public Health in collaboration with the College of Engineering and Computing. More information on the study can be found at bruise.gmu.edu.

Learn more here.

Recent News

03/13/2025

Zynext Ventures invests in Illexcor Therapeutics to advance novel oral therapy for sickle cell disease

Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its investment in Illexcor Therapeutics (Illexcor), a pioneering biopharmaceutical company developing next-generation oral therapies for sickle cell disease (SCD). This investment underscores Zynext Ventures’ commitment to supporting disruptive healthcare innovations that address significant unmet medical needs. Illexcor is developing

03/05/2025

Virginia Catalyst Awards $3.2 Million in Grants to Support Life Sciences in the Commonwealth

The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it has awarded $3.2 million in grants to four life and bioscience projects in the Commonwealth of Virginia. These projects were awarded in Grant Round 17. “The Catalyst works to help industry partners and academic investigators to raise follow-on

02/27/2025

Hourigan Strengthens Leadership in Advanced Manufacturing and Data Centers with Key Appointments

Hourigan is expanding its leadership team to support the firm’s growing presence in two of the region’s most technical and high-demand industries: advanced manufacturing and data centers. Hourigan has named Mark Hourigan, Jr. to lead its advanced manufacturing and logistics sector and Mark Rainey to oversee its mission-critical and data center expansion. These appointments build